Natural History Museum attacked over links to 'illegal' Israeli company

 

Ken Loach: The film director is one of 21 signatories to a letter attacking the museum over links to Ahava DSL
Ken Loach: The film director is one of 21 signatories to a letter attacking the museum over links to Ahava DSL

The Natural History Museum is today accused by a coalition of prominent academics and cultural figures of helping to break international law by leading a research project which involves an Israeli cosmetics company based in an “illegal” settlement in the occupied West Bank.

In a letter to The Independent, leading scientists and the film directors Mike Leigh and Ken Loach, condemn the London museum - which is the fourth most visited in Britain - for its research collaboration with Ahava - Dead Sea Laboratories (DSL), which sells beauty products based on minerals extracted from the Dead Sea.

The museum, which has a substantial academic research team, is co-ordinating NANORETOX, a European Union-funded project looking at any risks to human health and the environment posed by so-called nanoparticles - microscopic engineered materials which scientists are developing for multiple uses from cancer treatment to double glazing.

Ahava-DSL, which is one of a dozen institutions and companies involved in the project including two University of London colleges, has its registered headquarters listed in Israel but most of its activities are carried out in Mitzpe Shalem, a Jewish settlement on the edge of the Dead Sea in the West Bank.

Settlements in the Occupied Territories have been declared illegal under international law by the United Nations and the International Court of Justice. But despite international condemnation, the Israeli government insists that a large number of the settlements, including more than 120 on the West Bank, are not illegal.

In their letter, the 21 signatories, who include the eminent biologist Sir Patrick Bateson, president of the Zoological Society of London, and leading intellectual Sir Jonathan Miller, claim that the Natural History Museum’s connection with Ahava-DSL means that it is “co-ordinating an activity that breaks international law”.

They said: “[Ahava-DSL] extracts, processes and exports Palestinian resources to generate profits that fund an illegal settlement. Israel’s settlement project has been held... to break international law. Organisations which aid and abet this process may well themselves be found to be in violation.

“We find it almost inconceivable that a national institution of the status of the Natural History Museum should have put itself in this position. We call on the museum to take immediate steps to terminate its involvement in [the project] and to establish safeguards that protect against any comparable entanglement.”

The NANORETOX project began in December 2008 and is due to conclude at the end of this year, although campaigners say the involvement of Ahava-DSL has only now come to their attention. The company, which has conducted extensive research on nanoparticles for its products, was appointed to the project to supply materials and carry out toxicity tests.

The Natural History Museum yesterday defended its role in the research, saying that Ahava-DSL was chosen from a listed of scientific partners approved by the European Commission and suggested that any decision to boycott the project could be a challenge to “academic freedom”.

In a statement, Professor Ian Owens, the musuem’s director of science, said: “We work within the legal and policy boundaries established by politicians and policy makers, and would not participate in any academic or educational boycotts that could restrict academic freedom.”

Ahava-DSL, which has been the subject of a boycott campaign targeting its shops in Europe and America, did not respond to requests for a comment. The company has previously said that the Dead Sea mud and materials used in its products are excavated from Israeli land outside the occupied territories and that Mitzpe Shalem is not an illegal settlement.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in